Prevention of hepatocellular carcinoma: Progress and challenges

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) is a lethal cancer for both men and women and is caused by multiple risk factors. Most patients with HCC have an underlying liver disease caused by either chronic viral infection due to hepatitis B or hepatitis C virus or non-viral etiologic risk factors such as alcohol, fatty liver disease, dietary aflatoxin exposure, smoking and diabetes mellitus. While these risk factors are progressively and persistently damaging the liver, the majority of patients show very few symptoms of HCC. By the time symptoms appear the cancer is typically at a very advanced stage with limited options for treatment. In order to prevent death from HCC, it is therefore critically important to reduce the prevalence of the major risk factors, identify and treat those at high risk for development of HCC, and institute effective surveillance strategies for early diagnosis and treatment of HCC. This article reviews the recent progress and current challenges to the prevention of HCC.

Original languageEnglish (US)
Pages (from-to)49-64
Number of pages16
JournalMinerva Gastroenterologica e Dietologica
Volume58
Issue number1
StatePublished - Mar 2012

Fingerprint

Hepatocellular Carcinoma
Liver Diseases
Aflatoxins
Virus Diseases
Fatty Liver
Hepatitis B
Hepacivirus
Early Diagnosis
Neoplasms
Diabetes Mellitus
Smoking
Alcohols
Liver
Therapeutics

Keywords

  • Carcinoma, hepatocellular
  • Hepatitis B
  • Hepatitis C
  • Virus diseases

ASJC Scopus subject areas

  • Gastroenterology
  • Internal Medicine
  • Nutrition and Dietetics
  • Endocrinology, Diabetes and Metabolism

Cite this

Prevention of hepatocellular carcinoma : Progress and challenges. / Shire, A. M.; Roberts, Lewis Rowland.

In: Minerva Gastroenterologica e Dietologica, Vol. 58, No. 1, 03.2012, p. 49-64.

Research output: Contribution to journalArticle

@article{e1f6c8eeff30479e973e45e8a67e2b45,
title = "Prevention of hepatocellular carcinoma: Progress and challenges",
abstract = "Hepatocellular carcinoma (HCC) is a lethal cancer for both men and women and is caused by multiple risk factors. Most patients with HCC have an underlying liver disease caused by either chronic viral infection due to hepatitis B or hepatitis C virus or non-viral etiologic risk factors such as alcohol, fatty liver disease, dietary aflatoxin exposure, smoking and diabetes mellitus. While these risk factors are progressively and persistently damaging the liver, the majority of patients show very few symptoms of HCC. By the time symptoms appear the cancer is typically at a very advanced stage with limited options for treatment. In order to prevent death from HCC, it is therefore critically important to reduce the prevalence of the major risk factors, identify and treat those at high risk for development of HCC, and institute effective surveillance strategies for early diagnosis and treatment of HCC. This article reviews the recent progress and current challenges to the prevention of HCC.",
keywords = "Carcinoma, hepatocellular, Hepatitis B, Hepatitis C, Virus diseases",
author = "Shire, {A. M.} and Roberts, {Lewis Rowland}",
year = "2012",
month = "3",
language = "English (US)",
volume = "58",
pages = "49--64",
journal = "Minerva Gastroenterologica",
issn = "0026-4776",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "1",

}

TY - JOUR

T1 - Prevention of hepatocellular carcinoma

T2 - Progress and challenges

AU - Shire, A. M.

AU - Roberts, Lewis Rowland

PY - 2012/3

Y1 - 2012/3

N2 - Hepatocellular carcinoma (HCC) is a lethal cancer for both men and women and is caused by multiple risk factors. Most patients with HCC have an underlying liver disease caused by either chronic viral infection due to hepatitis B or hepatitis C virus or non-viral etiologic risk factors such as alcohol, fatty liver disease, dietary aflatoxin exposure, smoking and diabetes mellitus. While these risk factors are progressively and persistently damaging the liver, the majority of patients show very few symptoms of HCC. By the time symptoms appear the cancer is typically at a very advanced stage with limited options for treatment. In order to prevent death from HCC, it is therefore critically important to reduce the prevalence of the major risk factors, identify and treat those at high risk for development of HCC, and institute effective surveillance strategies for early diagnosis and treatment of HCC. This article reviews the recent progress and current challenges to the prevention of HCC.

AB - Hepatocellular carcinoma (HCC) is a lethal cancer for both men and women and is caused by multiple risk factors. Most patients with HCC have an underlying liver disease caused by either chronic viral infection due to hepatitis B or hepatitis C virus or non-viral etiologic risk factors such as alcohol, fatty liver disease, dietary aflatoxin exposure, smoking and diabetes mellitus. While these risk factors are progressively and persistently damaging the liver, the majority of patients show very few symptoms of HCC. By the time symptoms appear the cancer is typically at a very advanced stage with limited options for treatment. In order to prevent death from HCC, it is therefore critically important to reduce the prevalence of the major risk factors, identify and treat those at high risk for development of HCC, and institute effective surveillance strategies for early diagnosis and treatment of HCC. This article reviews the recent progress and current challenges to the prevention of HCC.

KW - Carcinoma, hepatocellular

KW - Hepatitis B

KW - Hepatitis C

KW - Virus diseases

UR - http://www.scopus.com/inward/record.url?scp=84860308049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860308049&partnerID=8YFLogxK

M3 - Article

C2 - 22419004

AN - SCOPUS:84860308049

VL - 58

SP - 49

EP - 64

JO - Minerva Gastroenterologica

JF - Minerva Gastroenterologica

SN - 0026-4776

IS - 1

ER -